Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $31.2000 (-4.88%) ($31.0000 - $41.5300) on Wed. Oct. 4, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 17.31% (three month average) | RSI | 88 | Latest Price | $31.2000(-4.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 6.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 40.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) ARKK(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -8.655% in a week (0% probabilities). GLD(-8%) GDX(-8%) TLT(-7%) SLV(-7%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -8.655% (StdDev 17.31%) | Hourly BBV | 0 () | Intraday Trend | -22.2% | | | |
|
5 Day Moving Average | $30.17(3.41%) | 10 Day Moving Average | $26.11(19.49%) | 20 Day Moving Average | $19.74(58.05%) | To recent high | -9.6% | To recent low | 365.7% | Market Cap | $615m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |